<DOC>
	<DOCNO>NCT00322712</DOCNO>
	<brief_summary>Chart Review patient pancreatic cancer treat combination irinotecan , oxaliplatin cetuximab .</brief_summary>
	<brief_title>INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated UNM Cancer</brief_title>
	<detailed_description>Chart Review describe clinical outcome patient pancreatic cancer treat combination irinotecan , oxaliplatin cetuximab .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Patients unresectable/metastatic pancreatic cancer treat UNM Cancer Research Treatment Center . Not specify .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>